(NP (NP (NNS Effects)) (PP (IN of) (NP (NN CD45))) (PP (IN on) (NP (NN NF-kappa) (NN B))) (. .))
(NP (NP (NNS Implications)) (PP (IN for) (NP (NP (NN replication)) (PP (IN of) (NP (NN HIV-1))))) (. .))
(S (NP-SBJ-10 (NP (VBN Increased) (NNS levels)) (PP (IN of) (NP (NP (NN replication)) (PP (IN of) (NP (DT the) (NN HIV) (NN type) (CD 1)))))) (VP (VBP are) (VP (VBN observed) (NP (-NONE- *-10)) (PP-TMP (IN after) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (JJ infected) (NN T) (NNS cells))) (PP (IN through) (NP (DT the) (NN TCR))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ (JJ anti-CD45) (NNS antibodies)) (VP (VBP inhibit) (NP (NP (DT these) (NNS effects)) (PP (IN in) (NP (NP (NNS cells)) (PP (IN from) (NP (JJ infected) (NNS individuals))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP-SBJ (PRP we)) (VP (VBD examined) (NP (NP (NNS interrelationships)) (PP (IN between) (NP-COOD (NP (NN CD45)) (CC and) (NP (NN HIV-1))))) (ADVP (RB further))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD measured) (NP (NP (NNS effects)) (PP (IN on) (NP (DT the) (NN HIV-1) (NN LTR))) (PP-COOD (PP (IN in) (NP (NP (NN T) (NN cell) (NNS lines)) (SBAR (WHNP-11 (WDT that)) (S (NP-SBJ-12 (-NONE- *T*-11)) (VP (VBD were) (VP (VBN stimulated) (NP (-NONE- *-12)) (PP (IN with) (NP (NP (NNS antibodies)) (PP (IN against) (NP (NN CD45))))))))))) (CC and) (PP (IN in) (NP (NP (DT those)) (SBAR (WHNP-13 (WDT that)) (S (NP-SBJ (-NONE- *T*-13)) (VP (VBD lacked) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN CD45))) (PP (IN on) (NP (PRP$ their) (NNS surfaces)))))))))))) (. .))
(S (ADVP (RB First)) (, ,) (NP-SBJ (JJ anti-CD45) (NNS antibodies)) (VP (VP-COOD (VP (VBD did) (RB not) (VP (VB affect) (NP (JJ basal) (NP (-NONE- *RNR*-100))))) (CC but) (VP (VBD decreased) (NP (JJ activated) (NP (-NONE- *RNR*-100))))) (NP-100 (NP (NNS levels)) (PP (IN of) (NP (NP (NN expression)) (PP (IN from) (NP (DT the) (NN HIV-1) (NN LTR))))))) (. .))
(S (ADVP (RB Second)) (, ,) (NP-SBJ (NP (NN T) (NNS cells)) (, ,) (SBAR (WHNP-14 (WDT which)) (S (NP-SBJ (-NONE- *T*-14)) (VP-COOD (VP (VBP lack) (NP (NN CD45))) (CC and) (VP (MD can) (RB not) (VP (VB signal) (PP (IN via) (NP (DT the) (NN TCR)))))))) (, ,)) (VP (VBD supported) (NP (NP (JJR higher) (NNS levels)) (PP (IN of) (NP-COOD (NP (JJ viral) (NN replication)) (CC and) (NP (NN gene) (NN expression)))))) (. .))
(S (NP-SBJ (DT This)) (VP (VBD was) (PP-PRD (JJ due) (TO to) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ active) (NN NF-kappa) (NN B) (NNS complexes))) (PP (IN in) (NP (NP (DT the) (NN nucleus)) (PP (IN of) (NP (JJ CD45-) (NN T) (NNS cells)))))))) (. .))
(S (ADVP (RB Additionally)) (, ,) (NP-SBJ (JJ infected) (NN T) (NNS cells)) (VP (VBD displayed) (NP (NP (JJR lower) (NNS levels)) (PP (IN of) (NP (NN CD45)))) (PP (IN on) (NP (PRP$ their) (NNS surfaces)))) (. .))
(S (ADVP (RB Thus)) (, ,) (NP-SBJ (NN CD45)) (VP (VBZ plays) (NP (DT an) (JJ active) (NN role)) (PP-COOD (PP (IN in) (NP (NP (DT the) (NN physiology)) (PP (IN of) (NP (NN T) (NNS cells))))) (CC and) (PP (IN in) (NP (NP (DT the) (NN replication)) (PP (IN of) (NP (NN HIV-1))))))) (. .))
